At first glance, activating the glucagon receptor seems counterproductive for a diabetes or weight loss medication
All of the staff I interacted with was very nice and welcoming

Furthermore, these pathways have also been linked to appetite regulation, modulation of gastric emptying, and cardiovascular effects ( Semaglutide and liraglutide effects on central nervous system regulation GLP-1 and GLP-1RA are involved in the activation of various central nervous system (CNS) processes, including satiety, thermogenesis, blood pressure, neurogenesis, and inflammation reduction ( Obesity has been associated with chronic inflammation, and GLP-1RA can modulate these inflammatory processes ( Moreover, GLP-1 promotes neurogenesis by reducing inflammation and decreasing the expression of proinflammatory cytokines IL-6, IL-10, and microglial activation ( Studies have observed that GLP-1RA decreases food intake, slows gastric emptying, and promotes the release of hormones such as leptin and peptide YY, involved in satiety ( Metabolic effects Semaglutide and liraglutide on insulin secretion The effect of GLP-1 and GLP-1RA in pancreatic -cells promotes glucose catabolism and insulin secretion ( Semaglutide, liraglutide and glucose homeostasis Liraglutide and semaglutide are mainly prescribed for the treatment of DM2 ( Lipid metabolism Semaglutide and Liraglutide effects on lipid metabolism GLP-1RA drugs have been associated with reduced food intake and body weight loss ( de novo lipogenesis

Regular monitoring of INR (International Normalised Ratio) is advised if taken together
Metabolism addiction in pancreatic cancer
The FLOW trial